These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30821090)

  • 1. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
    Choi J; Choi GH; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Kim KM
    Liver Int; 2019 May; 39(5):985-994. PubMed ID: 30821090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.
    Hartl J; Ehlken H; Sebode M; Peiseler M; Krech T; Zenouzi R; von Felden J; Weiler-Normann C; Schramm C; Lohse AW
    J Hepatol; 2018 Apr; 68(4):754-763. PubMed ID: 29180000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R-LIVER).
    Schregel I; Papp M; Sipeki N; Kovats PJ; Taubert R; Engel B; Campos-Murguia A; Dalekos GN; Gatselis N; Zachou K; Milkiewicz P; Janik MK; Raszeja-Wyszomirska J; Ytting H; Braun F; Casar C; Sebode M; Lohse AW; Schramm C;
    Liver Int; 2024 Oct; 44(10):2687-2699. PubMed ID: 39037185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
    Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE;
    J Hepatol; 2024 Aug; 81(2):227-237. PubMed ID: 38527524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis.
    Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA
    Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis.
    Hartl J; Ehlken H; Weiler-Normann C; Sebode M; Kreuels B; Pannicke N; Zenouzi R; Glaubke C; Lohse AW; Schramm C
    J Hepatol; 2015 Mar; 62(3):642-6. PubMed ID: 25457202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
    Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
    Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis.
    Khonde P; Choudhury S; Spies NC; Naz N; Stoll J; Fleckenstein J; He M; Ballentine S; Kulkarni S
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102442. PubMed ID: 39103121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
    Porta G; de Carvalho E; Santos JL; Gama J; Bezerra JA;
    J Pediatr; 2021 Feb; 229():95-101.e3. PubMed ID: 33500120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH; Gearry RB; Frampton CM; Stedman CA
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.
    Li YN; Ma H; Zhou L; Zhang J; Guo LP; Li SQ; Qian YQ; Wang BM
    Chin Med J (Engl); 2016 Oct; 129(20):2434-2440. PubMed ID: 27748335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
    Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort.
    Grossar L; Raevens S; Van Steenkiste C; Colle I; De Vloo C; Orlent H; Schouten J; Gallant M; Van Driessche A; Lefere S; Devisscher L; Geerts A; Van Vlierberghe H; Verhelst X
    JHEP Rep; 2024 Sep; 6(9):101149. PubMed ID: 39247177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of poor response to therapy in Autoimmune Hepatitis.
    Muratori P; Lalanne C; Bianchi G; Lenzi M; Muratori L
    Dig Liver Dis; 2016 Sep; 48(9):1078-81. PubMed ID: 27378707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis.
    Gerussi A; Halliday N; Saffioti F; Bernasconi DP; Roccarina D; Marshall A; Thorburn D
    Dig Liver Dis; 2020 Jul; 52(7):761-767. PubMed ID: 32473882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M;
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.